Notably, there were significant negative correlations between FPR2 expression levels and seizure frequency in FCDIIb patients (Figure 6C; r = −0.6165, p = .0434) and TSC patients (Figure 6F; r = −0.6367, p = .0351), but the obvious correlations were not observed for the other clinical variables. This evidence concerns the gene FPR2 and tuberous sclerosis.